References
Kansu E.The pathophysiology of chronic graft-versus-host disease. Int J Hematol. 2004;79:209–215.
Graze PR, Gale RP. Chronic graft-versus-host disease: a syndrome of disordered immunity. Am J Med. 1979;66:611–620.
Shulman H, Striker G, Deeg H, Kennedy M, StorbR, Thomas ED. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation. Glomerular thromboses and tubular injury. New Engl J Med. 1981;305:1392–1395.
Ikee R,Yamamoto K, Kushiyama T, Imakiire T, Suzuki S, Miura S. Recurrent nephrotic syndrome associated with graft-versus-host disease. Bone Marrow Transplant. 2004;34:1005–1006.
Oliveira JSR, Bahia D, Franco M, Balda C, Stella S, Kerbauty J. Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal. Bone Marrow Transplant. 1999;23:99–101.
Bruijin JA, van Eleven EH, Hogendoorn PCW et al. Murine chronic graft-versus-host disease as a model for lupus nephritis. Am J Pathol. 1988;130:639–641.
Hirano T, Akashi T, Keira T, et al. Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome. Clin Pharmacol Ther. 2000;68:532–540.
Leontsini M. Mesangiolysis. Hippokratia. 2003;7:147–151.
Hebert MJ, Fish D, Madore F, et al. Mesangiolysis associated with bone marrow transplantation: new insights on possible etiologic factors. Am J Kidney Dis. 1994;23:882–883.
Antignac C, Gubler MC, Leverger G, Broyer M, Habib R. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int. 1989;35:1336–1344.
Author information
Authors and Affiliations
About this article
Cite this article
Kawakami, K., Watanabe, Y., Mukai, K. et al. Nephrotic Syndrome with Extensive Mesangiolysis as a Clinical Manifestation of Chronic Graft-versus-Host Disease (GVHD). Int J Hematol 82, 270–272 (2005). https://doi.org/10.1532/IJH97.05074
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1532/IJH97.05074